Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Nov 17, 2021
- Accession no.
- 0001447362-21-000259
- Filed
- Nov 17, 2021
- Trade date
- Nov 15-16, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $861.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2021 | Common Stock | MOption exerciseAcquired | +16,406 | $2.36 | +$38,718.16 | 302,424 | Direct | |
| Nov 15, 2021 | Common Stock | SSaleDisposed | −15,394 | $52.47F1 | −$807,723.18 | 287,030 | Direct | |
| Nov 15, 2021 | Common Stock | SSaleDisposed | −1,012 | $53.04F2 | −$53,676.48 | 286,018 | Direct | |
| Nov 16, 2021 | Common Stock | MOption exerciseAcquired | +15,409 | $3.72 | +$57,321.48 | 301,427 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2021 | Common Stock | MOption exerciseDisposed | −16,406 | $0.00 | $0 | 0 | Direct | |
| Nov 16, 2021 | Common Stock | MOption exerciseDisposed | −15,409 | $0.00 | $0 | 20,686 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $52.000 to $52.995, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F2
This transaction was executed in multiple trades at prices ranging from $53.000 to $53.170, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.